71 related articles for article (PubMed ID: 16618714)
1. Methylation of the IL-12Rbeta2 gene as novel tumor escape mechanism for pediatric B-acute lymphoblastic leukemia cells.
Airoldi I; Cocco C; Di Carlo E; Disarò S; Ognio E; Basso G; Pistoia V
Cancer Res; 2006 Apr; 66(8):3978-80. PubMed ID: 16618714
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation of IL-12Rbeta2 gene in lung adenocarcinoma cells is associated with unfavorable prognosis.
Suzuki M; Iizasa T; Nakajima T; Kubo R; Iyoda A; Hiroshima K; Nakatani Y; Fujisawa T
Ann Surg Oncol; 2007 Sep; 14(9):2636-42. PubMed ID: 17602269
[TBL] [Abstract][Full Text] [Related]
3. The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies.
Airoldi I; Di Carlo E; Banelli B; Moserle L; Cocco C; Pezzolo A; Sorrentino C; Rossi E; Romani M; Amadori A; Pistoia V
J Clin Invest; 2004 Jun; 113(11):1651-9. PubMed ID: 15173892
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-12 receptor beta2: from cytokine receptor to gatekeeper gene in human B-cell malignancies.
Pistoia V; Cocco C; Airoldi I
J Clin Oncol; 2009 Oct; 27(28):4809-16. PubMed ID: 19720917
[TBL] [Abstract][Full Text] [Related]
5. The interleukin-12 and interleukin-12 receptor system in normal and transformed human B lymphocytes.
Airoldi I; Guglielmino R; Carra G; Corcione A; Gerosa F; Taborelli G; Trinchieri G; Pistoia V
Haematologica; 2002 Apr; 87(4):434-42. PubMed ID: 11940489
[TBL] [Abstract][Full Text] [Related]
6. A novel polymorphic GATA site in the human IL-12Rbeta2 promoter region affects transcriptional activity.
van Rietschoten JG; Westland R; van den Bogaard R; Nieste-Otter MA; van Veen A; Jonkers RE; van der Pouw Kraan TC; den Hartog MT; Wierenga EA
Tissue Antigens; 2004 Jun; 63(6):538-46. PubMed ID: 15140029
[TBL] [Abstract][Full Text] [Related]
7. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
Piloto O; Nguyen B; Huso D; Kim KT; Li Y; Witte L; Hicklin DJ; Brown P; Small D
Cancer Res; 2006 May; 66(9):4843-51. PubMed ID: 16651440
[TBL] [Abstract][Full Text] [Related]
8. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.
Ying J; Gao Z; Li H; Srivastava G; Murray PG; Goh HK; Lim CY; Wang Y; Marafioti T; Mason DY; Ambinder RF; Chan AT; Tao Q
Br J Haematol; 2007 Mar; 136(6):829-32. PubMed ID: 17341268
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.
Campo Dell'Orto M; Banelli B; Giarin E; Accordi B; Trentin L; Romani M; te Kronnie G; Basso G
Oncol Rep; 2007 Aug; 18(2):417-23. PubMed ID: 17611665
[TBL] [Abstract][Full Text] [Related]
10. Lineage-specific silencing of human IL-10 gene expression by promoter methylation in cervical cancer cells.
Szalmás A; Bánáti F; Koroknai A; László B; Fehér E; Salamon D; Gergely L; Minárovits J; Kónya J
Eur J Cancer; 2008 May; 44(7):1030-8. PubMed ID: 18378443
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning of interleukin-12 receptor beta2 chain and its expression in dogs.
Kitamiya E; Iwasaki T; Momoi Y
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):221-8. PubMed ID: 15963820
[TBL] [Abstract][Full Text] [Related]
12. Chromatin remodeling by the SWI/SNF-like BAF complex and STAT4 activation synergistically induce IL-12Rbeta2 expression during human Th1 cell differentiation.
Letimier FA; Passini N; Gasparian S; Bianchi E; Rogge L
EMBO J; 2007 Mar; 26(5):1292-302. PubMed ID: 17304212
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
Kioi M; Kawakami M; Shimamura T; Husain SR; Puri RK
Cancer; 2006 Sep; 107(6):1407-18. PubMed ID: 16902988
[TBL] [Abstract][Full Text] [Related]
14. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
[TBL] [Abstract][Full Text] [Related]
16. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
[TBL] [Abstract][Full Text] [Related]
17. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
[TBL] [Abstract][Full Text] [Related]
19. Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma.
Cooper LJ; Ausubel L; Gutierrez M; Stephan S; Shakeley R; Olivares S; Serrano LM; Burton L; Jensen MC; Forman SJ; DiGiusto DL
Cytotherapy; 2006; 8(2):105-17. PubMed ID: 16698684
[TBL] [Abstract][Full Text] [Related]
20. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
